Jazz Pharmaceuticals JAZZ Change in AP
Change in AP at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.
The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's change in ap.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's change in AP?
- Jazz Pharmaceuticals (JAZZ) reported change in AP of -$21.4M in Q1 2026.
- How has Jazz Pharmaceuticals's change in AP changed year-over-year?
- Jazz Pharmaceuticals's change in AP decreased by 212.0% year-over-year, from $19.1M to -$21.4M.
- What does change in AP mean?
- The change in the amount of money the company owes to its suppliers.
- How do you interpret change in AP?
- An increase in accounts payable is a source of cash, while a decrease is a use of cash.
- How does change in AP compare across companies?
- Standard metric; companies with strong bargaining power often maintain higher payable balances.